Preoperative Pain Management for L4-5 Listhesis Decompression-Fusion Surgery
For a patient undergoing L4-5 decompression-fusion surgery, implement multimodal opioid-sparing analgesia starting preoperatively with acetaminophen, NSAIDs (if no contraindications), and a single low-dose gabapentinoid, while continuing any existing chronic opioid therapy without interruption.
Core Preoperative Analgesic Strategy
The foundation of preoperative pain management should be multimodal, opioid-sparing analgesia to minimize postoperative opioid requirements and associated complications 1, 2.
Specific Preoperative Medications
Administer the following combination 1-2 hours before surgery:
Acetaminophen (Paracetamol): Age-adjusted dosing, typically 1000mg orally 1, 2
Non-selective NSAID or COX-2 inhibitor: Unless contraindicated by renal dysfunction (creatinine clearance <50 mL/min), atherothrombotic disease, or concurrent therapeutic anticoagulation 2
- NSAIDs provide the most significant morphine-sparing effect when combined with opioids
- Do NOT use NSAIDs with therapeutic-dose anticoagulants (increases severe bleeding risk 2.5-fold) 2
Single-dose gabapentinoid (gabapentin or pregabalin): Use the lowest effective dose to limit sedation, dizziness, and visual disturbances 1
- Pregabalin ≤75mg or gabapentin equivalent
- Adjust for age and renal function
- Do NOT continue beyond a single preoperative dose unless treating neuropathic pain 1
Critical Timing Consideration
Administer these medications with timing that achieves peak pharmacodynamic effect at surgical incision to maximize multimodal opioid-sparing benefits 1.
Management of Patients on Chronic Opioid Therapy
If Patient is NOT on Buprenorphine
Continue all chronic opioid medications through the morning of surgery 3. The evidence strongly supports continuation rather than discontinuation:
- Stopping opioids preoperatively increases withdrawal risk without improving outcomes
- Patients on chronic opioids will require higher-than-normal postoperative doses regardless 4
- Plan for opioid-tolerant dosing strategies postoperatively
If Patient IS on Buprenorphine
This scenario requires specific management based on the 2019 PAIN consensus 4:
For patients on ≤12mg sublingual buprenorphine daily:
- Continue buprenorphine through surgery without interruption
- Expect to use higher-than-normal doses of full mu-agonist opioids postoperatively (2-4 days) 4
For patients on >12mg sublingual buprenorphine daily:
- Taper to 12mg sublingual 2-3 days before surgery 4
- Continue at this reduced dose perioperatively
- Plan for multimodal analgesia and regional techniques
Critical pitfall to avoid: Older recommendations suggested discontinuing buprenorphine 72 hours preoperatively for moderate-to-severe pain surgeries 4. However, more recent consensus (2019) favors continuation to prevent relapse of opioid use disorder, which carries significant morbidity and mortality risk 4.
Additional Preoperative Considerations
Avoid Preoperative Anxiolytics
Do NOT routinely prescribe benzodiazepines or other sedatives preoperatively, especially in elderly patients 1. Preoperative education reduces anxiety adequately without pharmacologic intervention and avoids synergistic sedation with opioids.
Dexamethasone
Consider dexamethasone 8mg IV at induction for both antiemetic effects and postoperative pain reduction 2. This does not increase bleeding risk when combined with NSAIDs 2.
Ketamine Planning
For spine fusion surgery (high pain expected), plan for intraoperative ketamine at ≤0.5 mg/kg/h after induction, discontinued 30 minutes before surgery end 2. This provides anti-hyperalgesic effects and 30% reduction in chronic postoperative pain risk.
Common Pitfalls to Avoid
Do not withhold NSAIDs unnecessarily: The evidence for anastomotic leak after colorectal surgery does not apply to spine surgery 2
Do not use multiple doses of gabapentinoids: Single preoperative dose only to minimize sedation that compounds with opioids 1
Do not discontinue buprenorphine in patients with opioid use disorder: Risk of relapse outweighs theoretical analgesic benefits 4
Do not prescribe modified-release opioids preoperatively: Use immediate-release formulations only 5
Do not assume renal function is normal: Adjust NSAID and gabapentinoid doses for creatinine clearance 1, 2
Algorithm Summary
Patient Assessment
├─ On chronic opioids?
│ ├─ Yes, buprenorphine >12mg → Taper to 12mg over 2-3 days, continue
│ ├─ Yes, buprenorphine ≤12mg → Continue unchanged
│ └─ Yes, other opioids → Continue unchanged
│
└─ Contraindications check:
├─ Renal (CrCl <50) → Avoid/adjust NSAIDs and gabapentinoids
├─ Atherothrombosis → Avoid COX-2 inhibitors
└─ Therapeutic anticoagulation → Avoid NSAIDs
Preoperative medications (1-2h before surgery):
├─ Acetaminophen 1000mg PO
├─ NSAID or COX-2 inhibitor (if no contraindications)
├─ Single low-dose gabapentinoid (adjust for age/renal function)
└─ Dexamethasone 8mg IV at inductionThis approach prioritizes quality of life and minimizes morbidity by preventing opioid-related complications, reducing chronic pain development, and avoiding relapse in patients with substance use disorders 4, 1, 2.